Actualités CDT Equity Inc - CDT | Actions NASDAQ

Outils de qualité professionnelle, pour des investisseurs individuels.

CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing

NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today...

CDT Equity Announces Debt Update and New Loan Facility

NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today...

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 28, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today...

CDT Announces Canadian Patent for AZD5904 in Male Infertility

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 27, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today...

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 07, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes...

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 06, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today...

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today...

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 07, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today...

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today...

CDT Equity Inc. Announces Reverse Stock Split

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) announces...

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 23, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today...

CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today...

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 12, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today...

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 05, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today...

CDT Positions for Transformational Growth

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 04, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) advances...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

CDT Equity Inc (CDT)

Outils de qualité professionnelle, pour des investisseurs individuels.

CDT Equity Inc (CDT) Actualités

CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing

CDT Equity Announces Debt Update and New Loan Facility

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter

CDT Announces Canadian Patent for AZD5904 in Male Infertility

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

CDT Equity Inc. Announces Reverse Stock Split

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

CDT Positions for Transformational Growth

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

CDT Equity Inc (CDT)

Outils de qualité professionnelle, pour des investisseurs individuels.

CDT Equity Inc (CDT) Actualités

CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing

CDT Equity Announces Debt Update and New Loan Facility

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter

CDT Announces Canadian Patent for AZD5904 in Male Infertility

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

CDT Equity Inc. Announces Reverse Stock Split

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

CDT Positions for Transformational Growth

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités